à terapia contra o câncer e nos prognósticos, pode reduzir significativamente a ansiedade vivenciada por crianças com câncer e suas famílias.
Coley, W. B. (1933). The treatment of sarcoma of the long bones. Annals of Surgery, 97 (3), 434–460. Crom, W. R. (1994). Pharmacokinetics in the child. Environmental Health Perspectives, 102 (suppl. 11), 111–118. CureSearch. (2019). Clinical trials. Extraído de: http://curesearch.org/ Clinical-Trials de Alarcon, P. A., Al-Rahawan, M. M., Metzger, M. e Fernandez, K. S. (20 de março de 2017). Pediatric Hodgkin lymphoma workup. Medscape. Extraído de: http://emedicine.medscape.com/article/987101-workup de la Morena, M. T. e Gatti, R. A. (2011). A history of bone marrow transplantation. Hematology/Oncology Clinics of North America, 25 (1), 1–15. doi:10.1016/j.hoc.2010.11.001 Deng, G. e Cassileth, B. (2014). Integrative oncology: An overview. American Society of Clinical Oncology Educational Book, 2014, 233– 242. doi:10.14694/EdBook_AM.2014.34.233 Denny, C., Wechsler, D. S. e Sakamoto, K. M. (2016). Biology of childhood cancer. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 63-81). Filadélfia, PA: Wolters Kluwer. DiPiro, J. T., Spruill, W. J., Wade, W. E., Blouin, R. A. e Pruemer, J. M. (2010). Concepts in clinical pharmacokinetics (5 a ed., pp. 1–17). Bethesda, MD: American Society of Health-System Pharmacists. Disis, M. L. (2014). Mechanism of action of immunotherapy. Seminars in Oncology, 41 (5), S3–S13. doi:10.1053/j.seminoncol.2014.09.004 Dranoff, G., (2004). Cytokines in cancer pathogenesis and cancer therapy. Nature Reviews Cancer, 4 (1), 11–22. doi:10.1038/nrc1252 Eche, I. J. (2014). Diagnostic and staging procedures. Em N. Kline (Ed.), Essentials of pediatric oncology nursing: A core curriculum (4 a ed., pp. 102–106). Chicago, IL: Association of Pediatric Hematology/ Oncology Nurses. Erba, H. P. (2015). Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission. American Journal of Hematology, 90 (3), 242–249. doi:10.1002/ajh.23902 Ermoian, R. P., Fogh, S. E., Braunstein, S., Mishra, K. K. e Haas-Kogan, D. A. (2016). General principles of radiation oncology. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 362-379). Filadélfia, PA: Wolters Kluwer. Ettinger, A. G, Echtenkamp, D., Harley, J., Wills, M. S. e McNeil, S. B. (2011). Chemotherapy. Em C. Baggott, D. Fochtman, G. V. Foley e K. P. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4 a ed., pp. 326-382). Glenview, IL: Association of Pediatric Hematology/Oncology Nurses. Fernandez, C. V., Geller, J. I., Ehrlich, P. F., Hill, D. A., Kalapurakal, J. A. e Dome, J. S. (2016). Renal tumors. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 753- 771). Filadélfia, PA: Wolters Kluwer. Foley, G. V. e Fergusson, J. H. (2011). History, issues, and trends. Em C. R. Baggott, D. Fochtman, G. V. Foley e K. P. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4 a ed., pp. 2–34). Glenview, IL: Association of Pediatric Hematology/ Oncology Nurses. Forte, K. (2001). Pediatric oncology nursing: Providing care through decades of change. Journal of Pediatric Oncology Nursing, 18 (4), 154–163. doi:10.1053/jpon.2001.24796 Gallamini, A., Barrington, S. F., Biggi, A., Chauvie, S., Kostakoglu, L., Gregianin, M., . . . Hutchings, M. (2014). The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica, 99 (6), 1107–1113. http://doi.org/10.3324/haematol.2013.103218 Gillis, N. K., Patel, J. N. e Innocenti, F. (2014). Clinical implementation of germ line cancer pharmacogenetic variants during the next- generation sequencing era. Clinical Pharmacology and Therapeutics, 95 (3), 269–280. doi:10.1038/clpt.2013.214
Referências Abrams, D. I. e Weil, A. T. (2014). Integrative oncology (2ª ed.). Nova York, NY: Oxford University Press. Adamson, P. C., Blaney, S. M., Bagatell, R., Skolnick, J. M. e Balis, F. M. (2016). General principles of chemotherapy. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 239–315). Filadélfia, PA: Wolters Kluwer. Alberts, B., Johnson, A., Lewis, J., Morgan, D., Raff, M., Roberts, K. e Walter, P. (2015). Molecular biology of the cell (6ª ed.). Nova York, NY: Garland Science. Al-Hasani, R. e Bruchas, M. R. (2011). Molecular mechanisms of opioid receptor–dependent signaling and behavior. Anesthesiology, 115 (6), 1363–1381. doi:10.1097/ALN.0b013e318238bba6 Allen, C. E., Kamdar, K. Y., Bollard, C. M. e Gross, T. G. (2016). Malignant non-Hodgkin lymphomas in children. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 587- 603). Filadélfia, PA: Wolters Kluwer. Allen-Rhoades, W. e Steuber, C. P. (2016). Clinical assessment and differential diagnosis of the child suspected with cancer. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 101-111). Filadélfia, PA: Wolters Kluwer. American Cancer Society. (2014). The history of cancer. Extraído de: http://www.cancer.org/acs/groups/cid/documents/ webcontent/002048-pdf.pdf American Cancer Society. (2017). Cancer facts & figures 2017. Atlanta, GA: Autor. Analysis of germline cancer pharmacogenetic variants and solid tumor profiling using next generation sequencing. (s.d.). Extraído de: https://translationalsoftware.com/wp-content/uploads/2015/12/ Translational%20Software%20-%20Germline%20Parmacogenomics%20 for%20Cancer.pdf Andersen, R. L., Johnson, D. J. e Patel, J. N. (2016). Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways. Pharmacogenomics, 17 (4), 417–434. doi:10.2217/pgs.15.178 Ballen, K. K., Gluckman, E. e Broxmeyer, H. E. (2013). Umbilical cord blood transplantation: The first 25 years and beyond. Blood, 122( 4), 491–498. doi:10.1182/blood-2013-02-453175 British Society for Immunology. (2016). Bite sized immunology. Extraído de: http://www.bitesized.immunology.org Brodeur, G. M., Hogarty, M. D., Bagatell, R., Mosse, Y. P. e Maris, J. M. (2016). Neuroblastoma. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 772–797). Filadélfia, PA: Wolters Kluwer. Call, M.E., Stiehm, E. R. e Feldweg, A. M. (2016). Antigen presenting cells. Em T. W. Post (Ed.), UpToDate. Disponível em https://www. uptodate.com. Acesso em 16 de setembro de 2016. Campana, D. e Pui, C. (2017). Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia. Blood, 129 (14), 1913–1918. Extraído de: https://doi.org/10.1182/blood-2016-12-725804. Cancer Information Support Network. (2013). Oncogenes, tumor-suppressor genes and DNA repair genes. Extraído de: http:// cisncancer.org/research/what_we_know/advances/oncogenes.html Chang, Y. J. e Huang, X. J. (2013). Donor lymphocyte infusions for relapse after allogeneic transplantation: When, if and for whom? Blood Reviews, 27 (1), 55–62. doi:10.1016/j.blre.2012.11.002 Children’s Oncology Group (COG). (s.d.). What is a clinical trial? Extraído de: https://childrensoncologygroup.org/index.php/ what-is-a-clinical-trial
36 Plano de Estudos de Quimioterapia e Bioterapia Pediátrica: Quarta Edição
Powered by FlippingBook